Furthermore, a novel small molecule, namely IACS-010759, which is an inhibitor of OXPHOS undergoing clinical development, showed a potent antitumor efficacy in SMARCA4-mutant lung cancers [218]. Here, SMARCA4 is linked to lung cancer.